Patient-led Management of BPH: From Watchful Waiting to Self-management of LUTS

European Urology, Supplements

Volumn 5, Issue 12, 2006, Pages 704-709

  Emberton, Mark ^a  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Self management; Watchful waiting

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DUTASTERIDE; PROSTATE SPECIFIC ANTIGEN; PYGEUM AFRICANUM EXTRACT; RETINOL; SABAL EXTRACT; SELENIUM; STEROID 5ALPHA REDUCTASE INHIBITOR;

ALGORITHM; BLADDER NECK STENOSIS; DATA ANALYSIS; HUMAN; LIFESTYLE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; RISK FACTOR; SELF CARE; SYMPTOM; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA; URETHRA DISEASE; UROFLOWMETRY;

EID: 33746699537     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2006.06.008     Document Type: Review

References (32)

1. Sarma A.V., Jacobson D.J., McGree M.E., et al. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997. J Urol 173 (2005) 2048-2053
2. DuBeau C.E., Yalla S.V., and Resnick N.M. Improving the utility of urine flow rate to exclude outlet obstruction in men with voiding symptoms. J Am Geriatr Soc 46 (1998) 1118-1124
3. Flanigan R.C., Reda D.J., Wasson J.H., et al. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 160 (1998) 12-17
4. Djavan B., Fong Y.K., Harik M., et al. Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years. Urology 64 (2004) 1144-1148
5. Emberton M. The hallmarks of BPH progression and risk factors. Eur Urol Suppl 2 8 (2003) 2-7
6. Gannon K., Glover L., O'Neill M., and Emberton M. Men and chronic illness: a qualitative study of LUTS. J Health Psychol 9 (2004) 411-420
7. Nørby B., Nordling J., and Mortensen S. Lower urinary tract symptoms in the Danish population: a population-based study of symptom prevalence, health-care seeking behavior and prevalence of treatment in elderly males and females. Eur Urol 47 (2005) 817-823
8. Badia X., Rodriguez F., Carballido J., et al. Influence of sociodemographic and health status variables on the American Urological Association symptom scores in patients with lower urinary tract symptoms. Urology 57 (2001) 71-77
9. Clemens J.Q., Brown S.O., Kozloff L., and Calhoun E.A. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol 175 (2006) 963-966 discussion 967
10. Netto Junior N.R., and de Lima M.L. The influence of patient education level on the International Prostatic Symptom Score. J Urol 154 (1995) 97-99
11. Hong S.J., Rayford W., Valiquette L., and Emberton M. The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int 95 (2005) 15-19
12. Jacobsen S.J., Guess H.A., Panser L., et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med 2 (1993) 729-735
13. Hunter D.J., and Berra-Unamuno A. Treatment-seeking behaviour and stated preferences for prostatectomy in Spanish men with lower urinary tract symptoms. Br J Urol 79 (1997) 742-748
14. Scarpa R.M. Lower urinary tract symptoms: what are the implications for the patients?. Eur Urol 40 Suppl 4 (2001) 12-20
15. Stoevelaar H.J., Van de Beek C., Casparie A.F., McDonnell J., and Nijs H.G. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?. J Urol 161 (1999) 133-138
16. Ryan M., and Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 320 (2000) 1530-1533
17. Llewellyn-Thomas H.A., Williams J.I., Levy L., and Naylor C.D. Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia. Med Decis Making 16 (1996) 262-282
18. Watson V., Ryan M., Brown C.T., et al. Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. J Urol 172 (2004) 2321-2325
19. Brown C.T., and Emberton M. Could self-management challenge pharmacotherapy as a long-term treatment for uncomplicated lower urinary tract symptoms?. Curr Opin Urol 14 (2004) 7-12
20. Newman S., Steed L., and Mulligan K. Self-management interventions for chronic illness. Lancet 364 (2004) 1523-1537
21. Brown C.T., Van Der Meulen J., Mundy A.R., and Emberton M. Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey. BJU Int 92 (2003) 53-57
22. Wolters R., Wensing M., van Weel C., and Grol R. The effect of a distance-learning programme on patient self-management of lower urinary tract symptoms (LUTS) in general practice: a randomised controlled trial. Eur Urol 46 (2004) 95-101
23. Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 90 (2002) 649-654
24. Meigs J.B., Mohr B., Barry M.J., Collins M.M., and McKinlay J.B. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935-944
25. Prezioso D., Catuogno C., Galassi P., et al. Life-style in patients with LUTS suggestive of BPH. Eur Urol 40 Suppl 1 (2001) 9-12
26. Paterson J., Pinnock C.B., and Marshall V.R. Pelvic floor exercises as a treatment for post-micturition dribble. Br J Urol 79 (1997) 892-897
27. Burgio K.L. Influence of behavior modification on overactive bladder. Urology 60 (2002) 72-76 discussion 77
28. Mattiasson A., Blaakaer J., Hoye K., and Wein A.J. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 91 (2003) 54-60
29. Brown C.T., van der Meulen J., Mundy A.R., O'Flynn E., and Emberton M. Defining the components of a self-management programme for men with uncomplicated lower urinary tract symptoms: a consensus approach. Eur Urol 46 (2004) 254-263
30. Brown CT, Coe J, Colpman D, et al. The effect on voiding patterns of a self-management programme of lifestyle and behavioural interventions for men with uncomplicated lower urinary tract symptoms. Abstract presented at the American Urological Association Annual Meeting, San Francisco, CA, 8-13 May 2004.
31. Current Controlled Trials Register. National Research Register serial number N0263115137. http://www.controlled-trials.com/mrct/trial/selfmanagement/1046/39145.html.
32. Goldman D.P., and Smith J.P. Can patient self-management help explain the SES health gradient?. Proc Natl Acad Sci U S A 99 (2002) 10929-10934